Cheng Zhou

Title: Cheng Zhou - Innovator in Fibrosis Treatment

Introduction

Cheng Zhou is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of fibrosis and related diseases. His innovative work has the potential to impact many lives by providing new methods for addressing these challenging health issues.

Latest Patents

Cheng Zhou holds a patent for "Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases." This invention involves a protein oligomer that comprises at least two NC-monomers of collagen 18, at least two endostatin domains of collagen 18, or at least two N-terminal peptides of the collagen 18 endostatin domain. The patent outlines its use in treating, ameliorating, or preventing fibrosis or fibrosis-associated diseases, as well as vascular endothelial growth factor (VEGF)-related diseases and matrix metalloproteinase (MMP)-related diseases. Furthermore, the invention is also applicable for detecting and diagnosing these conditions.

Career Highlights

Cheng Zhou is affiliated with the Deutsches Krebsforschungszentrum, a leading cancer research center in Germany. His work there focuses on advancing the understanding and treatment of various diseases, particularly those related to fibrosis. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Cheng Zhou has collaborated with esteemed colleagues such as Amir Abdollahi and Kashi Javaherian. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.

Conclusion

Cheng Zhou's contributions to the field of fibrosis treatment and diagnosis exemplify the impact of innovative research in medicine. His patent and ongoing work at the Deutsches Krebsforschungszentrum highlight the importance of collaboration and dedication in advancing healthcare solutions.